Factores determinantes del retraso de la función inicial del injerto renal
Cáncer de pulmón en mujeres, experiencia en nuestra área sanitaria en los últimos ocho años. Neumosur 2009; 21(1): 51 (Resumen).
Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.Scand J Prim Health Care. 2010 Dec;28(4):242-8. Epub 2010 Sep 27.
Prevalencia de SAHS y FRCV en Hospital Infanta Cristina de Badajoz. Neumosur 2009; 21(1): 55. (Resumen)
Malformaciones pulmonares en cirugía pediátrica
Supervivencia a los tres años en pacientes con carcinoma broncogénico estadio I: nuestra experiencia. Neumosur 2009; 21 (1): 26 (Resumen)
CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans. Pharmacogenomics J. 2010 Dec 7. [Epub ahead of print]
Tabaquismo y mortalidad en pacientes con neumonía extrahospitalaria (NEH). Nuestra experiencia. Neumosur 2009; 21 (1): 45 (Resumen)
AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis
AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis. N Engl J Med 2021; 385:1570-1580.DOI: 10.1056/NEJMoa2034279.Leer más..
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different do
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens. pulsar aquí Juan Pablo Frias MD,Michael A. Nauck MD,Joanna Van DO,Charles Benson MD,Ross Bray PhD,Xuewei Cui PhD,Zvonko Milicevic MD,Shweta Urva PhD,Axel Haupt MD,Deborah A. […]